Dr. Eric L. Simpson

Dermatology
3930 Se Division St, 
Portland, OR 
Accepting New Patients
Offers Telehealth
3930 Se Division St, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Simpson is a Dermatologist in Portland, Oregon. Dr. Simpson is rated as an Experienced provider by MediFind in the treatment of Epidermolytic Palmoplantar Keratoderma. His top areas of expertise are Atopic Dermatitis, Psoriasis, Plaque Psoriasis, and Actinic Keratosis. Dr. Simpson is currently accepting new patients.

His clinical research consists of co-authoring 434 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in OR
Hospital Affiliations
Ohsu Hospital And Clinics
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

UNIVERSITY PROFESSIONAL SERVICES
3930 Se Division St, Portland, OR 97202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Multicenter Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Multicenter Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Enrollment Status: Completed
Publish Date: May 24, 2023
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Enrollment Status: Terminated
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 12, 2020
Intervention Type: Other
Study Phase: Not Applicable
Group Eczema Education Visits:Impact on Patient and Family Quality of Life
Group Eczema Education Visits:Impact on Patient and Family Quality of Life
Enrollment Status: Completed
Publish Date: July 11, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: December 13, 2017
Intervention Type: Drug
Study Phase: Phase 2
Effects of a Novel Formulation of Fluocinonide 0.1% Cream on Skin Barrier Function in Atopic Dermatitis
Effects of a Novel Formulation of Fluocinonide 0.1% Cream on Skin Barrier Function in Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 11, 2017
Intervention Type: Drug
Study Phase: Phase 4
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 11, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

434 Total Publications

Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis.
Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: October 30, 2025
Similar Doctors
Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Michael J. Adler
Dermatology
Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Michael J. Adler
Dermatology
1414 Northwest Northrup Street, Suite 600, 
Portland, OR 
 (3.5 miles away)
503-223-3104
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Adler is a Dermatologist in Portland, Oregon. Dr. Adler is rated as an Advanced provider by MediFind in the treatment of Epidermolytic Palmoplantar Keratoderma. His top areas of expertise are Actinic Keratosis, Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Adler is currently accepting new patients.

Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Kevin B. Yarbrough
Dermatology
Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Kevin B. Yarbrough
Dermatology

Sunnybrook Medical Office

9900 Se Sunnyside Rd, 
Clackamas, OR 
 (5.7 miles away)
800-813-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kevin Yarbrough is a Dermatologist in Clackamas, Oregon. Dr. Yarbrough is rated as an Experienced provider by MediFind in the treatment of Epidermolytic Palmoplantar Keratoderma. His top areas of expertise are Atopic Dermatitis, Acne, Vascular Birthmark, and Familial Multiple Nevi Flammei. Dr. Yarbrough is currently accepting new patients.

Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Franklin Parker
Dermatology
Experienced in Epidermolytic Palmoplantar Keratoderma
Dr. Franklin Parker
Dermatology
3303 Sw Bond Ave, 
Portland, OR 
 (2.4 miles away)
503-494-4713
Languages Spoken:
English

Franklin Parker is a Dermatologist in Portland, Oregon. Dr. Parker is rated as an Advanced provider by MediFind in the treatment of Epidermolytic Palmoplantar Keratoderma. His top areas of expertise are Actinic Keratosis, Psoriasis, Pityriasis Rubra Pilaris, and Mycosis Fungoides.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Simpson's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 53 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile